期刊文献+

银屑病的转化医学研究 被引量:3

原文传递
导出
摘要 银屑病是一种常见的慢性皮肤炎症性疾病,对患者的生活质量和心理健康都造成严重影响。世界范围内的银屑病发病率约为2%~3%,银屑病药物的全球市场每年高达33亿美元。转化医学是一门新兴学科,涵盖了从基础科学到临床应用的各个方面,是创新药理学工具、生物标记、临床方法和技术的综合运用,其主要目的是将基础研究与临床实践联系起来,将科研创新成果转化成新的诊疗技术或医疗保健产品。转化医学的流程主要为三个阶段,分别为:T1阶段:将基础科学研究转化成临床疗效,即把有意义的基础科研成果转化成有潜力的临床项目;T2阶段:将临床疗效转化成临床效果,即对治疗药物的疗效和安全性进行评估研究;T3阶段:将临床效果转化成医疗保健措施,即进行实际临床验证工作,进入临床推广和大规模使用。银屑病等遗传性皮肤病学是我国出产高水平成果较多的一个专业领域,近年来我国在这方面取得一系列重要成果,因此,银屑病也将成为我国实践转化医学最理想的方向之一。
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2012年第10期758-760,共3页 Chinese Journal of Dermatology
  • 相关文献

参考文献19

  • 1Geraghty J. Adenomatous polyposis coli and translationalmedicine. Lancet, 1996, 348(9025): 422.
  • 2张学军.转化医学——皮肤科学发展必由之路[J].中华皮肤科杂志,2011,44(10):685-687. 被引量:1
  • 3Liu Y, Helms C, Liao W, et al. A genome -wide associationstudy of psoriasis and psoriatic arthritis identifies new diseaseloci. PLoS Genet, 2008,4(3): e1000041.
  • 4Nair RP,Stuart PE, Nistor I,et al. Sequence and haplotypeanalysis supports HLA-C as the psoriasis susceptibility 1 gene.Am J Hum Genet, 2006,78(5): 827-851.
  • 5Gandhi M, Alwawi E, Gordon KB.Anti-p40 antibodies ustek-inumab and briakinumab: blockade of interleukin-12 and inte-rleukin-23 in the treatment of psoriasis. Semin Cutan Med Surg,2010,29(1):48-52.
  • 6Remmers EF, Cosan F, Kirino Y,et al. Genome-wide associa-tion study identifies variants in the MHC class I, IL10, andIL23H-IL12RB2 regions associated with Beh9et s disease. NatGenet, 2010, 42(8): 698-702.
  • 7Bagel J, Lynde C,Tyring S, et al. Moderate to severe plaquepsoriasis with scalp involvement: A randomized, double-blind,placebo-controlled study of etanercept.J Am Acad Dermatol,2011.
  • 8Lippens S, Lefebvre S, Gilbert B, et al. Keratinocyte - specificablation of the NF-kB regulatory protein A20 (TNFAIP3 ) re-veals a role in the control of epidermal homeostasis. Cell DeathDiffer, 2011, 18(12): 1845-1853.
  • 9Bowes J, Orozco G, Flynn E, et al. Confirmation of TNIP1 andIL23A as susceptibility loci for psoriatic arthritis. Ann RheumDis, 2011,70(9): 1641-1644.
  • 10Nair RP, Ding J, Duffin KC, et ah Psoriasis bench to bedside:genetics meets immunology. Arch Dermatol, 2009,145(4): 462-464.

共引文献192

同被引文献26

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3059
  • 2廖康煌,阎春林,王漪.日光反应性皮肤型的测定及其意义 [J].中华皮肤科杂志,1995,28(5):287-289. 被引量:101
  • 3Ljosaa TM, Mork C, Stubhaug A, et al. Skin pain and skin discomfort is associated with quality of life in patients with psoriasis [J]. J Eur Acad Dermatol Venereal, 2012, 26(1):29-35.
  • 4Nograles KE, Zaba LC, Guttman-Yassky E, et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways [J]. Br J Dermatol, 2008, 159 (5): 1092-1102.
  • 5Ren V, Dao H Jr. Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis [J]. Clin Cosmet Investig Dermatol, 2013, 6: 75-80.
  • 6Goodman WA, Levine AD, Massari JV, et al. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells [J]. J Immunol, 2009, 183 (5): 3170-3176.
  • 7Arican O, Aral M, Sasmaz S, et al. Serum levels of TNF- alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity [J]. Mediators Inflamm, 2005, 2005 (5): 273-279.
  • 8Coimbra S, Oliveira H, Reis F, et al. Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-α levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy [J]. Br J Dermatol, 2010, 163(6): 1282-1290.
  • 9刘露,郭书萍,贾宝珍.活化信号转导和转录激活因子3和基质金属蛋白酶-2在寻常型银屑病皮损中的表达[J].山西医药杂志(上半月),2008,37(6):495-497. 被引量:3
  • 10刘百灵,赵建斌.辅助性T细胞17和调节性T细胞与皮肤病[J].国际皮肤性病学杂志,2012,38(2):127-129. 被引量:1

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部